0001209191-20-057329.txt : 20201106
0001209191-20-057329.hdr.sgml : 20201106
20201106173739
ACCESSION NUMBER: 0001209191-20-057329
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201104
FILED AS OF DATE: 20201106
DATE AS OF CHANGE: 20201106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEST JEFFREY N
CENTRAL INDEX KEY: 0001244921
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06639
FILM NUMBER: 201295466
MAIL ADDRESS:
STREET 1: 6950 COLUMBIA GATEWAY DR STE 400
CITY: COLUMBIA
STATE: MD
ZIP: 21046
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAGELLAN HEALTH INC
CENTRAL INDEX KEY: 0000019411
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060]
IRS NUMBER: 581076937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4801 E. WASHINGTON ST
CITY: PHOENIX
STATE: AZ
ZIP: 85034
BUSINESS PHONE: 800-642-1716
MAIL ADDRESS:
STREET 1: 4801 E. WASHINGTON ST
CITY: PHOENIX
STATE: AZ
ZIP: 85034
FORMER COMPANY:
FORMER CONFORMED NAME: MAGELLAN HEALTH SERVICES INC
DATE OF NAME CHANGE: 19960226
FORMER COMPANY:
FORMER CONFORMED NAME: CHARTER MEDICAL CORP
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-04
0
0000019411
MAGELLAN HEALTH INC
MGLN
0001244921
WEST JEFFREY N
14100 MAGELLAN PLAZA
MARYLAND HEIGHTS
MO
63043
0
1
0
0
SVP & Controller
Ordinary Common Stock, $0.01 par value
2020-11-04
4
X
0
1298
68.50
A
24313
D
Ordinary Common Stock, $0.01 par value
2020-11-04
4
X
0
1183
66.57
A
25496
D
Ordinary Common Stock, $0.01 par value
2020-11-04
4
S
0
2481
80.0005
D
23015
D
Ordinary Common Stock, $0.01 par value
2020-11-04
4
S
0
139
80.0005
D
22876
D
Stock Options (right to buy)
68.50
2020-11-04
4
X
0
1298
0.00
D
2027-03-03
Common Stock
1298
0
D
Stock Options (right to buy)
66.57
2020-11-04
4
X
0
1183
0.00
D
2029-03-02
Common Stock
1183
2365
D
This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at an average price of $80.0005. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
All of the stock options in this tranche have vested in full.
Not applicable.
Of the 3,548 stock options in this tranche, 1,183 vested on March 3, 2020 and have been exercised as of the date of reporting. The remainder of 2,365 stock options shall vest in equal increments on March 3, 2021 and 2022.
/s/ Jeffrey N. West
2020-11-06